Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | CCR1 | P32246 | 2/20 | 0.45 |
| ▸ | CCR5 | P51681 | 2/20 | 0.45 |
| ▸ | CCR8 | P51685 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | METAP1 | P53582 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.45 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | HTR7 | P34969 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16484524 | 1.00 | CYP2A6 (0.46) | CYP2A6LMNAKDM4ECCR1CCR5 | |
| SCHEMBL30109153 | 1.00 | CYP2A6 (0.46) | CYP2A6LMNAKDM4ECCR1CCR5 | |
| SCHEMBL5102763 | 0.98 | CYP2A6 (0.44) | CYP2A6LMNAKDM4ECCR1CCR5 | |
| SCHEMBL26849314 | 0.96 | CYP2A6 (0.46) | CYP2A6LMNAKDM4ECCR1CCR5 | |
| SCHEMBL15606465 | 0.92 | CYP2A6 (0.40) | CYP2A6LMNAKDM4ECCR1CCR5 | |
| SCHEMBL3141411 | 0.90 | CYP2A6 (0.41) | CYP2A6LMNAKDM4ECCR1CCR5 | |
| SCHEMBL19801900 | 0.89 | GRM5 (0.46) | CYP2A6KDM4ECCR1CCR5CCR8 | |
| SCHEMBL16307352 | 0.89 | GRM5 (0.43) | CYP2A6LMNAKDM4ECCR1CCR5 | |
| SCHEMBL15133751 | 0.89 | CYP2A6 (0.40) | CYP2A6LMNAKDM4ECCR1CCR5 | |
| SCHEMBL3133582 | 0.89 | CYP2A6 (0.40) | CYP2A6LMNAKDM4ECCR1CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210280804-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-09-09 | — | — | US | disclosed |
| US-20210280804-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-09-09 | — | — | US | disclosed |
| US-9682958-B2 | Ligands and their preparation | MERCK PATENT GMBH (DE) | 2017-06-20 | — | — | US | disclosed |
| US-9682958-B2 | Ligands and their preparation | MERCK PATENT GMBH (DE) | 2017-06-20 | — | — | US | disclosed |
| US-20150175574-A1 | Ligands And Their Preparation | MERCK PATENT GMBH (DE) | 2015-06-25 | — | — | US | disclosed |
| US-20150175574-A1 | Ligands And Their Preparation | MERCK PATENT GMBH (DE) | 2015-06-25 | — | — | US | disclosed |
| WO-2014015936-A1 | LIGANDS AND THEIR PREPARATION | MERCK PATENT GMBH (DE) | 2014-01-30 | — | — | WO | disclosed |
| EP-1683804-B1 | PLATINUM COMPLEX AND LUMINESCENT ELEMENT | TAKASAGO PERFUMERY CO LTD (JP) | 2013-07-31 | — | — | EP | disclosed |
| EP-1683804-B1 | PLATINUM COMPLEX AND LUMINESCENT ELEMENT | TAKASAGO PERFUMERY CO LTD (JP) | 2013-07-31 | — | — | EP | disclosed |
| US-7442797-B2 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-10-28 | — | — | US | disclosed |
| US-7442797-B2 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-10-28 | — | — | US | disclosed |
| US-7442797-B2 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-10-28 | — | — | US | disclosed |
| US-20070103060-A1 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-05-10 | — | — | US | disclosed |
| US-20070103060-A1 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-05-10 | — | — | US | disclosed |
| US-20070103060-A1 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-05-10 | — | — | US | disclosed |
| EP-1683804-A2 | PLATINUM COMPLEX AND LUMINESCENT ELEMENT | Takasago International Corporation (JP) | 2006-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070103060-A1 | Platinum complex and light emitting device | UBE2D3, PCID2, CCND2 | CYP2A6 3224/4885LMNA 3397/4885KDM4E 3127/4885 |
| US-20210280804-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OTC | CYP2A6 3356/4885LMNA 4558/4885KDM4E 3290/4885 |
| US-20150175574-A1 | Ligands And Their Preparation | PNMT, DNMT1, DNMT3A | CYP2A6 2487/4885LMNA 1969/4885KDM4E 2509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.